Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
weight loss
obesity
drug shortages
Ro
Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters
Wed, 05/29/24 - 11:48 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Mounjaro
Novo blames US health system after criticism over Wegovy price, Bloomberg reports
Reuters
Tue, 05/28/24 - 10:43 am
Novo Nordisk
drug pricing
Ozempic
Wegovy
weight loss
GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData
BioSpace
Mon, 05/20/24 - 06:02 pm
GLP-1 agonist
weight loss
obesity
diabetes
Genetic profile may predict best response to weight-loss drug Wegovy
Reuters
Mon, 05/20/24 - 11:09 am
Novo Nordisk
Wegovy
genetics
obesity
weight loss
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate
BioSpace
Thu, 05/16/24 - 11:40 am
Roche
Genentech
CT-388
Carmot
weight loss
clinical trials
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters
BioSpace
Wed, 05/15/24 - 11:22 am
insulin
GLP-1 agonist
Novo Nordisk
weight loss
Wegovy
Ozempic
diabetes
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
Reuters
Mon, 05/13/24 - 10:17 pm
Novo Nordisk
Wegovy
weight loss
Aardvark raises $85M to target hunger, not appetite, as it contemplates IPO, pharma deals
San Diego Biotech Networks
Thu, 05/9/24 - 07:37 pm
Aardvark Therapeutics
R&D
weight loss
IPOs
funding
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Reuters
Wed, 04/24/24 - 09:59 am
Novo Nordisk
Wegovy
weight loss
Medicare
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
Motley Fool
Wed, 04/24/24 - 08:43 am
Eli Lilly
weight loss
Zepbound
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Reuters
Wed, 04/17/24 - 11:21 am
drug shortages
Eli Lilly
Zepbound
Mounjaro
diabetes
weight loss
US to see surge in new obesity drug launches in next five years
Biopharma Reporter
Tue, 04/16/24 - 10:11 pm
obesity
drug launches
weight loss
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Mon, 04/15/24 - 11:09 am
weight loss
Novo Nordisk
CagriSema
Eli Lilly
orforglipro
Viking Therapeutics
VK-2735
Inversago Pharma
INV-202
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Novo Nordisk
Ozempic
Wegovy
EMA
obesity
weight loss
suicide
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Viking touts promising phase I data for weight-loss pill candidate
BioSpace
Tue, 03/26/24 - 11:35 am
Viking Therapeutics
clinical trials
obesity
weight loss
VK2735
Medicare to cover Novo’s weight-loss drug Wegovy for patients with heart disease
BioSpace
Fri, 03/22/24 - 10:58 am
Medicare
Novo Nordisk
weight loss
Wegovy
heart disease
Could Viking Therapeutics Become the Next Eli Lilly?
Motley Fool
Fri, 03/22/24 - 09:27 am
Viking Therapeutics
Eli Lilly
weight loss
VK-2735
Zepbound
Mounjaro
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »